Dr. Umbar Ghaffar, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 813 Founders Park Drive, Suite 203, Springdale, AR 72762 Phone: 479-463-2440 Fax: 479-463-2465 |
John Christopher Hey, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 813 Founders Park Dr E, Suite 203, Springdale, AR 72762 Phone: 479-463-2440 Fax: 479-463-2465 |
Michael Lowell Moulton, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 813 Founders Park Dr E, Springdale, AR 72762 Phone: 479-463-2440 Fax: 479-463-2465 |
Dr. Avin D Rekhi, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 813 Founders Park Dr E, Springdale, AR 72762 Phone: 479-463-2440 Fax: 479-463-2465 |
Dr. Fred L Smardo, MD Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 307 S Thompson St, Suite C, Springdale, AR 72764 Phone: 479-751-6004 Fax: 479-751-3408 |
Dr. John H Wu, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 813 Founders Park Dr E, Suite 203, Springdale, AR 72762 Phone: 479-463-2440 Fax: 479-463-2465 |
News Archive
More than seventy percent of people who contract Hepatitis C will live with the virus that causes it for the rest of their lives and some will develop serious liver disease including cancer. However, 30 to 40 percent of those infected somehow defeat the infection and get rid of the virus with no treatment. In this week's Advanced Online Publication at Nature, Johns Hopkins researchers working as part of an international team report the discovery of the strongest genetic alteration associated with the ability to get rid of the infection.
How well cancer patients fared after chemotherapy was affected by their social interaction with other patients during treatment, according to a new study by researchers at the National Human Genome Research Institute, part of the National Institutes of Health, and the University of Oxford in the United Kingdom.
When trace elements rise to toxic levels, bad things happen. Patients suffering from Alzheimer's and Parkinson's disease harbor significantly higher levels of zinc and iron in their brains than healthy patients.
PolyMedix, Inc. (OTC BB: PYMX, www.polymedix.com), an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders, and the University of Massachusetts, have received a Phase I Small Business Technology Transfer (STTR) contract in the amount of $100,000 to support research to identify lead antimicrobial compounds to effectively treat multi-drug resistant and biofilm-embedded bacteria.
Researchers from Manchester have begun a new study to determine whether blood sugar levels during pregnancy, lower than the level used to diagnose gestational diabetes, influences later levels of body fat in children and development of diabetes in mothers after giving birth.
› Verified 5 days ago